Health reform spurs private heart hospital to invest in state-run peer
The private, mainland-based Wuhan Asia Heart Hospital has acquired a state-owned hospital as it tries to seize the opportunities presented by the recently announced reforms in the health care sector.
The company signed an agreement with the Wuhan government last month to be the trustee of the hospital, known as No 7 Hospital, for 25 years.
Set up by a Hong Kong investor 10 years ago, Wuhan Asia Heart is now the third-largest hospital in China specialising in heart disease, having treated about 750,000 patients over the years.
Under the agreement, Wuhan Asia Heart will be responsible for the costs and capital investments of the No 7 Hospital, which will entitle it to profit from it, said Huang Ning, executive manager of Wuhan Asia Heart.
The hospital has already earmarked between 300 million yuan (HK$355 million) to 500 million yuan to revamp No 7 Hospital's facilities.
In November it acquired another private hospital, Xinjiang Cardiovascular Hospital, in Urumqi, for 300 million yuan.
![loading](https://assets-v2.i-scmp.com/production/_next/static/media/wheel-on-gray.af4a55f9.gif)